Copy reference, caption or embed code

Fig 3 - The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Fig. 3. Incidence of the composite endpoint bleeding/decompensation after 24 months according to (A) Child-Pugh-Stage, (B) MELD, (C) HVPG, and HVPG-response and occurrence of (D) any decompensation or (E) variceal (re)-bleeding only.
Incidence of the composite endpoint bleeding/decompensation after 24 months according to (A) Child-Pugh-Stage, (B) MELD, (C) HVPG, and HVPG-response and occurrence of (D) any decompensation or (E) variceal (re)-bleeding only.
Go to figure page
Reference
Caption
Embed code